🇺🇸 FDA
Patent

US 7622463

Dihydrodiazepines useful as inhibitors of protein kinases

granted A61KA61K31/551A61K45/06

Quick answer

US patent 7622463 (Dihydrodiazepines useful as inhibitors of protein kinases) held by Vertex Pharmaceuticals Incorporated expires Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Nov 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
42
CPC classes
A61K, A61K31/551, A61K45/06, A61P, A61P11/00